Severe vivax malaria in the Republic of Korea during the period 2000 to 2016.

[1]  H. Kwon,et al.  Severe Plasmodium vivax infection in Korea , 2017, Malaria Journal.

[2]  S. Antinori,et al.  Imported Plasmodium vivax malaria with severe thrombocytopaenia: can it be severe malaria or not? , 2016, Malaria Journal.

[3]  N. White,et al.  Severe vivax malaria: a systematic review and meta-analysis of clinical studies since 1900 , 2014, Malaria Journal.

[4]  R. Price,et al.  Severe Malarial Thrombocytopenia: A Risk Factor for Mortality in Papua, Indonesia , 2014, The Journal of infectious diseases.

[5]  K. Saravu,et al.  Severity in Plasmodium vivax malaria claiming global vigilance and exploration – a tertiary care centre-based cohort study , 2014, Malaria Journal.

[6]  A. Rodríguez-Morales,et al.  Anemia and thrombocytopenia in Plasmodium vivax malaria is not unusual in patients from endemic and non-endemic settings. , 2014, Travel medicine and infectious disease.

[7]  Cho Naing,et al.  Is Plasmodium vivax Malaria a Severe Malaria?: A Systematic Review and Meta-Analysis , 2014, PLoS neglected tropical diseases.

[8]  A. Lescano,et al.  Plasmodium vivax hospitalizations in a monoendemic malaria region: severe vivax malaria? , 2014, The American journal of tropical medicine and hygiene.

[9]  N. Ghanchi,et al.  Severe Plasmodium vivax Malaria in Pakistan , 2013, Emerging infectious diseases.

[10]  I. Rizvi,et al.  Complications associated with Plasmodium vivax malaria: a retrospective study from a tertiary care hospital based in Western Uttar Pradesh, India. , 2013, Annals of African medicine.

[11]  J. Verhave.  Experimental, therapeutic and natural transmission of Plasmodium vivax tertian malaria: scientific and anecdotal data on the history of Dutch malaria studies , 2013, Parasites & Vectors.

[12]  J. Baird.  Evidence and Implications of Mortality Associated with Acute Plasmodium vivax Malaria , 2013, Clinical Microbiology Reviews.

[13]  Q. Bassat,et al.  Postmortem characterization of patients with clinical diagnosis of Plasmodium vivax malaria: to what extent does this parasite kill? , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  Jae-Won Park,et al.  Status of Plasmodium vivax malaria in the Republic of Korea, 2008-2009: decrease followed by resurgence. , 2012, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[15]  I. Ahmed,et al.  Severe disease in children hospitalized with a diagnosis of Plasmodium vivax in south-eastern Pakistan , 2012, Malaria Journal.

[16]  C. Whitty,et al.  Risk factors for mortality from imported falciparum malaria in the United Kingdom over 20 years: an observational study , 2012, BMJ : British Medical Journal.

[17]  J. Acharya,et al.  Clinical features of children hospitalized with malaria--a study from Bikaner, northwest India. , 2010, The American journal of tropical medicine and hygiene.

[18]  A. Dash,et al.  Histopathology of fatal respiratory distress caused by Plasmodium vivax malaria. , 2009, The American journal of tropical medicine and hygiene.

[19]  J. Baird,et al.  Resistance to chloroquine by Plasmodium vivax at Alor in the Lesser Sundas Archipelago in eastern Indonesia. , 2009, The American journal of tropical medicine and hygiene.

[20]  M. Khatri,et al.  Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in northwestern India. , 2009, The American journal of tropical medicine and hygiene.

[21]  P. Siba,et al.  A trial of combination antimalarial therapies in children from Papua New Guinea. , 2008, The New England journal of medicine.

[22]  R. Price,et al.  Multidrug-Resistant Plasmodium vivax Associated with Severe and Fatal Malaria: A Prospective Study in Papua, Indonesia , 2008, PLoS medicine.

[23]  I. Elyazar,et al.  Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in northeastern Indonesian Papua. , 2007, The American journal of tropical medicine and hygiene.

[24]  W. Alecrim,et al.  Chloroquine-Resistant Plasmodium vivax, Brazilian Amazon , 2007, Emerging infectious diseases.

[25]  Purnomo,et al.  Very high risk of therapeutic failure with chloroquine for uncomplicated Plasmodium falciparum and P. vivax malaria in Indonesian Papua. , 2003, The American journal of tropical medicine and hygiene.

[26]  D. Raveh,et al.  Age as a risk factor for severe Plasmodium falciparum malaria in nonimmune patients. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  J. Chai.  Re-emerging Plasmodium vivax malaria in the Republic of Korea. , 1999, The Korean journal of parasitology.

[28]  S. Hoffman,et al.  Age-dependent susceptibility to severe disease with primary exposure to Plasmodium falciparum. , 1998, The Journal of infectious diseases.

[29]  D. Strickman,et al.  Reemergence of Plasmodium vivax malaria in the republic of Korea. , 1998, Emerging infectious diseases.

[30]  J. Chai,et al.  [Occurrence of tertian malaria in a male patient who has never been abroad]. , 1994, The Korean journal of parasitology.

[31]  J. P. Martin,et al.  Conquest of general paralysis. , 1972, British medical journal.

[32]  J. M. Hayman,et al.  Uncommon clinical manifestations of vivax malaria. , 1946, Journal of the American Medical Association.

[33]  T. C. Fong.  A STUDY OF THE MORTALITY RATE AND COMPLICATIONS FOLLOWING THERAPEUTIC MALARIA , 1937 .

[34]  P. Schlagenhauf,et al.  Risk factors associated with malaria deaths in travellers: a literature review. , 2015, Travel medicine and infectious disease.

[35]  Baird Jk.  Evidence and Implications of Mortality Associated with Acute Plasmodium vivax Malaria , 2013 .

[36]  P. G. Shute,et al.  A strain of Plasmodium vivax characterized by prolonged incubation: morphological and biological characteristics. , 1975, Bulletin of the World Health Organization.